Pharma Focus Asia

Pharma Focus Asia Pharma Focus Asia - Magazine for Pharma Industry Leaders
https://www.linkedin.com/company/pharmafocusasia/ Ltd.. Pharma Focus Asia offers . . .

Pharma Focus Asia is a half yearly publication from Ochre Media Pvt. It is the leading pharma title in print and digital versions serving the information needs of key executives from the worldโ€™s leading pharmaceutical companies. Pharma Focus Asia covers important issues and trends shaping the future of the pharma industry across Asia and rest of the world. Dedicated, reliable and accurate coverage of the industryโ€™s progress and
Incisive analysis to help its readers make informed decisions to stay ahead of the competition. The magazine provides cutting-edge and futuristic content on the pharma industry. The issues are broadly categorized into various sections:

Strategy
Research and Development
Manufacturing
Clinical Trials
Information Technology


The one-stop pharma destination www.pharmafocusasia.com features complete content from the Pharma Focus Asia magazine. Also find the latest pharma news, press releases, pharma industry reports, interviews, trends and pharma events updated on a daily basis. The magazine is supplemented by the monthly e-Newsletter: Verticaltalk Pharma. The readership

The magazineโ€™s readership includes the top C-level executives, senior industry executives, and key decision makers from the pharma industry in charge of spending. With a special focus on Asia, Pharma Focus Asia reaches out to the key industry leaders across Asia, Europe and the Americas.

๐‚๐ž๐ฅ๐ฅ ๐š๐ง๐ ๐ ๐ž๐ง๐ž ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ข๐ž๐ฌ are changing how complex diseases are treatedโ€”and APAC is stepping into a pivotal regulatory rol...
02/01/2026

๐‚๐ž๐ฅ๐ฅ ๐š๐ง๐ ๐ ๐ž๐ง๐ž ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ข๐ž๐ฌ are changing how complex diseases are treatedโ€”and APAC is stepping into a pivotal regulatory role.

Featured in Pharma Focus Asia Magazine โ€“ Issue 61, Wei Xia Ang, Senior Regulatory Compliance Lead, Cytiva, shares how evolving regulations, regional collaboration, and manufacturing innovation are shaping the future of CGTs in Asia-Pacific.

A must-read for pharma professionals, regulatory teams, and biotech innovators.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐ญ๐ก๐ž ๐ž-๐›๐จ๐จ๐ค: https://www.pharmafocusasia.com/magazine

๐‘๐ž๐š๐ ๐ญ๐ก๐ž ๐Ÿ๐ฎ๐ฅ๐ฅ ๐š๐ซ๐ญ๐ข๐œ๐ฅ๐ž: https://www.pharmafocusasia.com/biopharma/navigating-the-future-the-regulatory-revolution

CMC is no longer just a technical stepโ€”itโ€™s shaping regulatory success.In ๐๐ก๐š๐ซ๐ฆ๐š ๐…๐จ๐œ๐ฎ๐ฌ ๐€๐ฌ๐ข๐š ๐Œ๐š๐ ๐š๐ณ๐ข๐ง๐žโ€”๐ˆ๐ฌ๐ฌ๐ฎ๐ž ๐Ÿ”๐Ÿ, ๐‘๐ž๐ž๐ง๐š ๐๐š๐ญ...
31/12/2025

CMC is no longer just a technical stepโ€”itโ€™s shaping regulatory success.

In ๐๐ก๐š๐ซ๐ฆ๐š ๐…๐จ๐œ๐ฎ๐ฌ ๐€๐ฌ๐ข๐š ๐Œ๐š๐ ๐š๐ณ๐ข๐ง๐žโ€”๐ˆ๐ฌ๐ฌ๐ฎ๐ž ๐Ÿ”๐Ÿ, ๐‘๐ž๐ž๐ง๐š ๐๐š๐ญ๐ข๐ฅ (๐•๐, ๐‚๐Œ๐‚ ๐’๐ญ๐ซ๐š๐ญ๐ž๐ ๐ฒ, ๐’๐ฎ๐ฉ๐ฉ๐ฅ๐ฒ ๐‚๐ก๐š๐ข๐ง & ๐๐ซ๐จ๐ฃ๐ž๐œ๐ญ ๐Œ๐š๐ง๐š๐ ๐ž๐ฆ๐ž๐ง๐ญ, ๐†๐ซ๐ข๐ญ๐ฌ๐ญ๐จ๐ง๐ž ๐›๐ข๐จ) highlights how early CMC decisions help Asian biotech overcome FDA delays, CDMO risks, and biosimilar readiness challenges.

A must-read for pharma leaders preparing for global markets and accelerated approvals.

https://www.pharmafocusasia.com/biopharma/why-early-cmc-strategy-matters-for-asian-biotech

๐†๐ž๐ญ ๐ญ๐ก๐ž ๐Ÿ๐ฎ๐ฅ๐ฅ ๐ž-๐›๐จ๐จ๐ค ๐Ÿ๐ซ๐จ๐ฆ ๐จ๐ฎ๐ซ ๐ฐ๐ž๐›๐ฌ๐ข๐ญ๐ž ๐ญ๐จ๐๐š๐ฒ: https://www.pharmafocusasia.com/magazine

Biotherapeutics are driving a major shift in modern medicineโ€”from AI-enabled drug design to RNA therapies and CAR-T inno...
30/12/2025

Biotherapeutics are driving a major shift in modern medicineโ€”from AI-enabled drug design to RNA therapies and CAR-T innovations.

Featured in Pharma Focus Asia โ€“ Issue 61, this in-depth article by ๐Œ๐จ๐ก๐ ๐’๐ก๐š๐ก๐ข๐, ๐ˆ๐›๐ซ๐š๐ก๐ข๐ฆ ๐’๐š๐ฃ๐ข๐, ๐š๐ง๐ ๐Š๐ซ๐ข๐ฌ๐ญ๐ž๐ง ๐€๐ก๐ฅ๐ฌ๐œ๐ก๐ฐ๐ž๐๐ž highlights how data, technology, and collaboration are accelerating development while addressing manufacturing and access challenges.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐ญ๐ก๐ž ๐ž-๐›๐จ๐จ๐ค: https://www.pharmafocusasia.com/magazine

๐‘๐ž๐š๐ ๐ญ๐ก๐ž ๐Ÿ๐ฎ๐ฅ๐ฅ ๐š๐ซ๐ญ๐ข๐œ๐ฅ๐ž: https://www.pharmafocusasia.com/biopharma/advances-in-biotherapeutics-transforming



AI is transforming the pharmaceutical industryโ€”cutting drug development timelines, improving success rates, and strength...
29/12/2025

AI is transforming the pharmaceutical industryโ€”cutting drug development timelines, improving success rates, and strengthening patient-centric innovation.

The latest ๐๐ก๐š๐ซ๐ฆ๐š ๐…๐จ๐œ๐ฎ๐ฌ ๐€๐ฌ๐ข๐š ๐Œ๐š๐ ๐š๐ณ๐ข๐ง๐ž (๐ˆ๐ฌ๐ฌ๐ฎ๐ž ๐Ÿ”๐Ÿ) features an in-depth article by
Kasturi Pawar, Director of Formulation Development at Exelixis, Inc., highlighted how AI is shaping drug discovery, preclinical research, clinical trials, and post-market surveillance.

๐Ÿ“˜ Stay informed with expert perspectives shaping the future of pharma.

๐Ÿ‘‰ ๐•๐ข๐ฌ๐ข๐ญ ๐จ๐ฎ๐ซ ๐ฐ๐ž๐›๐ฌ๐ข๐ญ๐ž ๐ญ๐จ ๐ซ๐ž๐š๐ ๐ญ๐ก๐ž ๐š๐ซ๐ญ๐ข๐œ๐ฅ๐ž: https://www.pharmafocusasia.com/information-technology/exploring-artificial-intelligence-potential

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐ญ๐ก๐ž ๐ž-๐›๐จ๐จ๐ค: https://www.pharmafocusasia.com/magazine

AI is reshaping pharmacovigilanceโ€”but trust, accuracy, and fairness matter more than speed.In ๐๐ก๐š๐ซ๐ฆ๐š ๐…๐จ๐œ๐ฎ๐ฌ ๐€๐ฌ๐ข๐š ๐Œ๐š๐ ๐š๐ณ๐ข๐ง๐ž...
24/12/2025

AI is reshaping pharmacovigilanceโ€”but trust, accuracy, and fairness matter more than speed.

In ๐๐ก๐š๐ซ๐ฆ๐š ๐…๐จ๐œ๐ฎ๐ฌ ๐€๐ฌ๐ข๐š ๐Œ๐š๐ ๐š๐ณ๐ข๐ง๐ž โ€“ ๐ˆ๐ฌ๐ฌ๐ฎ๐ž ๐Ÿ”๐Ÿ, ๐‰๐จ๐ก๐ง ๐๐ซ๐š๐ฏ๐ž๐ž๐ง, ๐€๐ฌ๐ฌ๐จ๐œ๐ข๐š๐ญ๐ž ๐•๐ข๐œ๐ž ๐๐ซ๐ž๐ฌ๐ข๐๐ž๐ง๐ญ ๐š๐ญ ๐€๐œ๐œ๐ž๐ง๐ญ๐ฎ๐ซ๐ž, explains how hallucination and bias in Generative AI can influence drug safety decisionsโ€”and what pharma leaders must do to manage these risks responsibly.

From human oversight to explainable AI and regulatory alignment, this article outlines how GenAI can truly support patient protection worldwide.

๐€๐œ๐œ๐ž๐ฌ๐ฌ ๐ญ๐ก๐ž ๐š๐ซ๐ญ๐ข๐œ๐ฅ๐ž: https://www.pharmafocusasia.com/information-technology/toward-trustworthy-ai-in-pharma

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐ญ๐ก๐ž ๐ž-๐›๐จ๐จ๐ค ๐ง๐จ๐ฐ: https://www.pharmafocusasia.com/magazine

๐“๐ข๐ง๐ฒ ๐“๐ž๐œ๐ก. ๐๐ข๐  ๐ˆ๐ฆ๐ฉ๐š๐œ๐ญ. ๐“๐ซ๐š๐ง๐ฌ๐Ÿ๐จ๐ซ๐ฆ๐ข๐ง๐  ๐‹๐ฎ๐ง๐  ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ.Nanobots are emerging as a powerful solution to overcome toxi...
23/12/2025

๐“๐ข๐ง๐ฒ ๐“๐ž๐œ๐ก. ๐๐ข๐  ๐ˆ๐ฆ๐ฉ๐š๐œ๐ญ. ๐“๐ซ๐š๐ง๐ฌ๐Ÿ๐จ๐ซ๐ฆ๐ข๐ง๐  ๐‹๐ฎ๐ง๐  ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ.

Nanobots are emerging as a powerful solution to overcome toxicity, poor targeting, and invasive procedures in chronic lung diseases. From targeted cancer therapy to real-time monitoring and tissue regeneration, these nano-systems are changing respiratory care.

๐Ÿ“ ๐‘ญ๐’†๐’‚๐’•๐’–๐’“๐’†๐’… ๐’Š๐’ ๐‘ท๐’‰๐’‚๐’“๐’Ž๐’‚ ๐‘ญ๐’๐’„๐’–๐’” ๐‘จ๐’”๐’Š๐’‚ โ€“ ๐‘ฐ๐’”๐’”๐’–๐’† ๐Ÿ”๐Ÿ
โœ๏ธ ๐‘ฉ๐’š ๐‘ซ๐’Š๐’๐’†๐’”๐’‰ ๐‘ฒ๐’–๐’Ž๐’‚๐’“ ๐‘ช๐’‰๐’†๐’๐’๐’‚๐’‘๐’‘๐’‚๐’, ๐‘ฎ๐’‚๐’–๐’“๐’‚๐’— ๐‘ฎ๐’–๐’‘๐’•๐’‚, ๐‘บ๐’‚๐’„๐’‰๐’Š๐’ ๐‘ฒ๐’–๐’Ž๐’‚๐’“ ๐‘บ๐’Š๐’๐’ˆ๐’‰ & ๐‘ฒ๐’‚๐’Ž๐’‚๐’ ๐‘ซ๐’–๐’‚

๐‘๐ž๐š๐ ๐ญ๐ก๐ž ๐š๐ซ๐ญ๐ข๐œ๐ฅ๐ž: https://www.pharmafocusasia.com/manufacturing/tiny-tech-big-impact-the-rise-of-nanobots

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐ญ๐ก๐ž ๐ž-๐›๐จ๐จ๐ค: https://www.pharmafocusasia.com/magazine

Wearables are transforming clinical trials by capturing real-world patient dataโ€”continuously, remotely, and reliably.In ...
22/12/2025

Wearables are transforming clinical trials by capturing real-world patient dataโ€”continuously, remotely, and reliably.

In this expert-led article, ๐‘๐š๐ฌ๐ก๐ฆ๐ข ๐†๐ฎ๐ซ๐ง๐š๐ง๐ข, ๐‚๐„๐Ž ๐จ๐Ÿ ๐€๐Š๐“ ๐‡๐ž๐š๐ฅ๐ญ๐ก ๐€๐ง๐š๐ฅ๐ฒ๐ญ๐ข๐œ๐ฌ, highlights how wearable technologies improve trial efficiency, patient engagement, data quality, and real-world evidence generation across therapeutic areas like cardiology, neurology, oncology, and respiratory care.

A must-read for pharma leaders and healthcare professionals shaping the future of evidence-based medicine.

๐Ÿ‘‰ ๐‘๐ž๐š๐ ๐ญ๐ก๐ž ๐Ÿ๐ฎ๐ฅ๐ฅ ๐š๐ซ๐ญ๐ข๐œ๐ฅ๐ž ๐ก๐ž๐ซ๐ž: https://www.pharmafocusasia.com/clinical-trials/transforming-clinical-trials-harnessing-wearables-for-real-world-data

Strong preclinical outcomes start with the right discovery strategy. ๐Ÿ’Š๐Ÿ”ฌIn her latest article, ๐’๐ง๐ž๐ก๐š ๐’๐ข๐ญ๐š๐ซ๐š๐ฆ๐š๐ง, ๐๐ซ๐ข๐ง๐œ๐ข๐ฉ๐š๐ฅ...
19/12/2025

Strong preclinical outcomes start with the right discovery strategy. ๐Ÿ’Š๐Ÿ”ฌ

In her latest article, ๐’๐ง๐ž๐ก๐š ๐’๐ข๐ญ๐š๐ซ๐š๐ฆ๐š๐ง, ๐๐ซ๐ข๐ง๐œ๐ข๐ฉ๐š๐ฅ ๐’๐œ๐ข๐ž๐ง๐ญ๐ข๐ฌ๐ญ ๐š๐ญ ๐‚๐ก๐ข๐ฅ๐๐ซ๐ž๐งโ€™๐ฌ ๐‡๐จ๐ฌ๐ฉ๐ข๐ญ๐š๐ฅ ๐จ๐Ÿ ๐๐ก๐ข๐ฅ๐š๐๐ž๐ฅ๐ฉ๐ก๐ข๐š, explains why human-relevant model systems, AI-driven insights, and early validation are critical to building safer and more effective therapies.

๐…๐ž๐š๐ญ๐ฎ๐ซ๐ž๐ ๐ข๐ง ๐๐ก๐š๐ซ๐ฆ๐š ๐…๐จ๐œ๐ฎ๐ฌ ๐€๐ฌ๐ข๐š ๐Œ๐š๐ ๐š๐ณ๐ข๐ง๐ž โ€“ ๐ˆ๐ฌ๐ฌ๐ฎ๐ž ๐Ÿ”๐Ÿ

Download the e-book and stay informed on whatโ€™s shaping the future of drug development: https://www.pharmafocusasia.com/magazine

๐Ÿ‘‰ ๐•๐ข๐ฌ๐ข๐ญ ๐จ๐ฎ๐ซ ๐ฐ๐ž๐›๐ฌ๐ข๐ญ๐ž ๐ญ๐จ ๐ซ๐ž๐š๐ ๐ฆ๐จ๐ซ๐ž: https://www.pharmafocusasia.com/research-development/discovery-stage-the-bedrock-for-preclinical-development

๐๐ก๐š๐ซ๐ฆ๐š ๐…๐จ๐œ๐ฎ๐ฌ ๐€๐ฌ๐ข๐šโ€™๐ฌ ๐ž๐ฆ๐š๐ข๐ฅ ๐ง๐ž๐ฐ๐ฌ๐ฅ๐ž๐ญ๐ญ๐ž๐ซ is your weekly connection to what matters most in the pharma and life sciences spac...
18/12/2025

๐๐ก๐š๐ซ๐ฆ๐š ๐…๐จ๐œ๐ฎ๐ฌ ๐€๐ฌ๐ข๐šโ€™๐ฌ ๐ž๐ฆ๐š๐ข๐ฅ ๐ง๐ž๐ฐ๐ฌ๐ฅ๐ž๐ญ๐ญ๐ž๐ซ is your weekly connection to what matters most in the pharma and life sciences space. Built for professionals who want clarity, context, and credible insightsโ€”straight to their inbox.

๐ˆ๐ง๐ฌ๐ข๐๐ž ๐ž๐ฏ๐ž๐ซ๐ฒ ๐ž๐๐ข๐ญ๐ข๐จ๐ง:
โœ” Articles & expert interviews
โœ” Industry news, projects, and press releases
โœ” Tech trends, research insights, and events
โœ” Podcasts and the latest magazine updates

Join a growing community of pharma professionals.

๐’๐ฎ๐›๐ฌ๐œ๐ซ๐ข๐›๐ž ๐ญ๐จ๐๐š๐ฒ ๐š๐ง๐ ๐ฌ๐ก๐š๐ซ๐ž ๐ฐ๐ข๐ญ๐ก ๐ฒ๐จ๐ฎ๐ซ ๐œ๐จ๐ฅ๐ฅ๐ž๐š๐ ๐ฎ๐ž๐ฌ:
https://industry.pharmafocusasia.com/e-newsletters/1765962079-PFA-Dec-25.html

๐Ÿ‘‰ ๐•๐ข๐ฌ๐ข๐ญ ๐จ๐ฎ๐ซ ๐ฐ๐ž๐›๐ฌ๐ข๐ญ๐ž ๐ญ๐จ ๐ ๐ž๐ญ ๐ฌ๐ญ๐š๐ซ๐ญ๐ž๐: https://www.pharmafocusasia.com/subscribe

Asia is a ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐ฉ๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐ฆ๐š๐ง๐ฎ๐Ÿ๐š๐œ๐ญ๐ฎ๐ซ๐ข๐ง๐  leaderโ€”but regulatory fragmentation, slow approvals, and weak enforcement ...
18/12/2025

Asia is a ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐ฉ๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐ฆ๐š๐ง๐ฎ๐Ÿ๐š๐œ๐ญ๐ฎ๐ซ๐ข๐ง๐  leaderโ€”but regulatory fragmentation, slow approvals, and weak enforcement still delay patient access to new therapies.

In this powerful feature, ๐ƒ๐š๐ฏ๐ข๐ ๐๐ซ๐š๐ ๐š, ๐๐ก๐š๐ซ๐š๐ญ ๐‘๐š๐ฐ๐š๐ฅ, ๐š๐ง๐ ๐‹๐š๐ซ๐ซ๐ฒ ๐๐ซ๐š๐ ๐š highlight how AI and quantum computing can strengthen regulatory capacity, improve transparency, protect IP, and harmonise drug approvals across Asia-Pacific markets.

This is an article from the latest magazine released on ๐๐‡๐€๐‘๐Œ๐€ ๐…๐Ž๐‚๐”๐’ ๐€๐’๐ˆ๐€ ๐Œ๐€๐†๐€๐™๐ˆ๐๐„ โ€“ ๐ˆ๐ฌ๐ฌ๐ฎ๐ž ๐Ÿ”๐Ÿ: https://www.pharmafocusasia.com/magazine

Join the conversation on how technology can reshape pharma regulation and innovation across Asia.

๐‘๐ž๐š๐ ๐ญ๐ก๐ž ๐Ÿ๐ฎ๐ฅ๐ฅ ๐š๐ซ๐ญ๐ข๐œ๐ฅ๐ž ๐จ๐ง ๐จ๐ฎ๐ซ ๐ฐ๐ž๐›๐ฌ๐ข๐ญ๐ž: https://www.pharmafocusasia.com/strategy/modernising-asias-drug-regulations-ai-and-quantum-computing

The future of pharmacovigilance is becoming smarter and faster.In this insightful piece, ๐Œ๐š๐ซ๐ข๐š ๐‚๐š๐ซ๐จ๐ฅ๐ข๐ง๐š ๐๐ซ๐š๐ ๐š, ๐’๐ž๐ง๐ข๐จ๐ซ ๐๐•...
17/12/2025

The future of pharmacovigilance is becoming smarter and faster.

In this insightful piece, ๐Œ๐š๐ซ๐ข๐š ๐‚๐š๐ซ๐จ๐ฅ๐ข๐ง๐š ๐๐ซ๐š๐ ๐š, ๐’๐ž๐ง๐ข๐จ๐ซ ๐๐• ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ข๐ง๐  ๐€๐ฌ๐ฌ๐จ๐œ๐ข๐š๐ญ๐ž ๐š๐ญ ๐ˆ๐‚๐Ž๐ ๐ฉ๐ฅ๐œ, shares how Artificial Intelligence is supporting DSUR preparationโ€”helping PV teams manage massive safety datasets, improve efficiency, and meet regulatory timelines without compromising scientific judgment.

AI is not replacing expertsโ€”itโ€™s empowering them.

๐Ÿ‘‰ ๐‘๐ž๐š๐ ๐ญ๐ก๐ž ๐Ÿ๐ฎ๐ฅ๐ฅ ๐š๐ซ๐ญ๐ข๐œ๐ฅ๐ž ๐จ๐ง ๐จ๐ฎ๐ซ ๐ฐ๐ž๐›๐ฌ๐ข๐ญ๐ž ๐š๐ง๐ ๐ฌ๐ก๐š๐ซ๐ž ๐ฒ๐จ๐ฎ๐ซ ๐ญ๐ก๐จ๐ฎ๐ ๐ก๐ญ๐ฌ:
https://www.pharmafocusasia.com/articles/application-of-artificial-intelligence-in-development-safety

๐Ÿš€ ๐‡๐จ๐ญ ๐Ž๐Ÿ๐Ÿ ๐ญ๐ก๐ž ๐๐ซ๐ž๐ฌ๐ฌ! ๐๐ก๐š๐ซ๐ฆ๐š ๐…๐จ๐œ๐ฎ๐ฌ ๐€๐ฌ๐ข๐š ๐ˆ๐ฌ๐ฌ๐ฎ๐ž ๐Ÿ”๐Ÿ ๐ข๐ฌ ๐‡๐ž๐ซ๐ž! ๐Ÿš€Weโ€™re excited to announce the release of Pharma Focus Asia, Is...
16/12/2025

๐Ÿš€ ๐‡๐จ๐ญ ๐Ž๐Ÿ๐Ÿ ๐ญ๐ก๐ž ๐๐ซ๐ž๐ฌ๐ฌ! ๐๐ก๐š๐ซ๐ฆ๐š ๐…๐จ๐œ๐ฎ๐ฌ ๐€๐ฌ๐ข๐š ๐ˆ๐ฌ๐ฌ๐ฎ๐ž ๐Ÿ”๐Ÿ ๐ข๐ฌ ๐‡๐ž๐ซ๐ž! ๐Ÿš€

Weโ€™re excited to announce the release of Pharma Focus Asia, Issue 61โ€”your essential guide to the latest trends, technologies, and strategies shaping the pharmaceutical industry across Asia and beyond.

๐Ÿ”ฌ ๐–๐ก๐š๐ญโ€™๐ฌ ๐ˆ๐ง๐ฌ๐ข๐๐ž?
โ–ช In-depth articles on manufacturing, clinical trials, R&D, and digital transformation
โ–ช Insights from industry leaders and innovators
โ–ช The latest on pharma technology, strategy, and regulatory updates

Whether youโ€™re a senior executive, researcher, or pharma enthusiast, this issue is packed with valuable knowledge to keep you ahead in the fast-evolving pharma landscape.

๐‘๐ž๐š๐ ๐ญ๐ก๐ž ๐ง๐ž๐ฐ ๐ข๐ฌ๐ฌ๐ฎ๐ž ๐ง๐จ๐ฐ ๐ข๐ง ๐ฉ๐ซ๐ข๐ง๐ญ ๐จ๐ซ ๐ž-๐›๐จ๐จ๐ค ๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ! ๐Ÿ‘‰ ๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐ญ๐ก๐ž ๐ฅ๐š๐ญ๐ž๐ฌ๐ญ ๐ข๐ฌ๐ฌ๐ฎ๐ž:
https://www.pharmafocusasia.com/magazine

Address

111, 112 First Floor, Block 2, White House
Hyderabad
500016

Website

Alerts

Be the first to know and let us send you an email when Pharma Focus Asia posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Pharma Focus Asia:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category